The structures of nanocarriers capable of improve the transport of chemotherapeutic agents, as well as release O2 selectively in cancer cells, have decreased the hypoxic state with a downregulation of HIF-1α expression, resulting in a reduction in tumor growth and metastasis. The gene discussed is HIF1A; the disease is neoplasm.